Jennifer L. Holter, M.D. , assistant professor of hematology/oncology and assistant director of the blood and marrow transplant program at the University of Oklahoma Medical Center, answered these questions regarding compromised immune systems and intravenous gamma-globulin treatment.

Q :Who are the people most likely in need of this therapy?

A :Patients that genetically cannot make adequate amounts of imm...